L81.1 Chloasma

Name of the Condition

• Chloasma (ICD-10-CM Code: L81.1)

Summary

Chloasma, also known as melasma, is a common skin condition characterized by brown or gray-brown patches on the skin, typically affecting the face. These patches result from increased melanin production and are often symmetric, occurring on areas like the cheeks, forehead, nose, and upper lip. Chloasma is more prevalent in women and may be associated with hormonal changes or sun exposure.

Causes

The exact cause of chloasma is not fully understood, but it is linked to increased melanin production. Hormonal factors, such as pregnancy or the use of oral contraceptives, are common triggers. Sun exposure is a significant contributor, as ultraviolet (UV) light stimulates melanin production. Other potential factors include genetic predisposition and certain medications.

Risk Factors

Risk factors for chloasma include female gender, hormonal fluctuations (e.g., pregnancy, hormone therapy), sun exposure, darker skin types, and a family history of the condition. Use of photosensitizing medications or cosmetics may also increase risk.

Symptoms

Patients typically present with symmetric, irregularly shaped patches of hyperpigmentation on sun-exposed areas of the face. The patches may vary in size and intensity, ranging from light brown to dark brown. Chloasma does not cause physical discomfort but may affect cosmetic appearance.

Diagnosis

Diagnosis is primarily clinical, based on the characteristic appearance and distribution of patches. A dermatologist may use Wood’s lamp examination to assess pigment depth. In some cases, a skin biopsy may be performed to rule out other pigmentation disorders or underlying conditions.

Treatment Options

Treatment focuses on reducing pigmentation and preventing recurrence. Options include topical agents like hydroquinone, retinoids, or corticosteroids; chemical peels; and laser therapy. Strict sun protection with broad-spectrum sunscreen is essential to minimize worsening or recurrence.

Prognosis and Follow-Up

Chloasma often persists for months to years, with potential for improvement with treatment. Recurrence is common, especially with sun exposure or hormonal changes. Regular follow-up with a dermatologist is recommended to monitor progress and adjust treatment as needed.

Complications

While chloasma is not physically harmful, it may cause psychological distress due to cosmetic concerns. Prolonged sun exposure can exacerbate pigmentation, and some treatments carry risks of irritation or hyperpigmentation if not used properly.

Lifestyle & Prevention

Preventive measures include consistent use of broad-spectrum sunscreen, wearing protective clothing, and avoiding known triggers like hormonal medications if possible. Limiting sun exposure, especially during peak hours, is critical to reducing the risk of worsening or recurrence.

When to Seek Professional Help

Consult a healthcare provider if pigmentation changes are sudden, asymmetric, or accompanied by other symptoms (e.g., itching, bleeding). A dermatologist should evaluate persistent or worsening patches to rule out other skin conditions.

Tips for Medical Coders

When coding for chloasma, use ICD-10-CM code L81.1. Documentation should specify the location and characteristics of the patches, as well as any associated factors (e.g., pregnancy, sun exposure). Ensure the diagnosis is clearly supported by clinical findings to justify code assignment.